Alternative TFAP2A isoforms have distinct activities in breast cancer

por Berlato, Chiara, Chan, KaYi V, Price, Anna M, Canosa, Monica, Scibetta, Angelo G, Hurst, Helen C
Publicado 2011

Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer

por Gopinathan, Ganga, Berlato, Chiara, Lakhani, Anissa, Szabova, Ludmila, Pegrum, Colin, Pedrosa, Ana-Rita, Laforets, Florian, Maniati, Eleni, Balkwill, Frances R.
Publicado 2022

Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment

por Maniati, Eleni, Berlato, Chiara, Gopinathan, Ganga, Heath, Owen, Kotantaki, Panoraia, Lakhani, Anissa, McDermott, Jacqueline, Pegrum, Colin, Delaine-Smith, Robin M., Pearce, Oliver M.T., Hirani, Priyanka, Joy, Joash D., Szabova, Ludmila, Perets, Ruth, Sansom, Owen J., Drapkin, Ronny, Bailey, Peter, Balkwill, Frances R.
Publicado 2020

TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer

por Lecker, Laura S.M., Berlato, Chiara, Maniati, Eleni, Delaine-Smith, Robin, Pearce, Oliver M.T., Heath, Owen, Nichols, Samuel J., Trevisan, Caterina, Novak, Marian, McDermott, Jacqueline, Brenton, James D., Cutillas, Pedro R., Rajeeve, Vinothini, Hennino, Ana, Drapkin, Ronny, Loessner, Daniela, Balkwill, Frances R.
Publicado 2021